The Shift Toward US Pharmaceutical Manufacturing

Efficient Biologics Production

FDA’s Quality Management Maturity Program – Why should CDMOs adhere to the new CDER’s Rati

Ensuring Patient Safety: Decoding FDA’s Rating System for CDMOs

Resource savings through effective:
Global Trade Compliance in Drug Development

FDA’s Quality Management Maturity Program:
Why should CDMOs adhere to the new CDER’s Rating System?

Outsourcing Your Parenteral Manufacturing – Choosing the Optimal CDMO

The M.O. Behind Choosing a CDMO: Three Considerations for New Drug Developers

Casual Nexus – Episode Four: Strategies for HPAPI Containment to Enable Rapid Development and Production

Casual Nexus – Episode Three: Sterile Drug Product Manufacturing During a Global Pandemic

Casual Nexus – Episode One: Formulation Development and Clinical Supply of Aseptic Liposomal

Curia Signs on to Participate in Diversity Lab’s Mansfield Certification Program